About the Company
We do not have any company description for bioAffinity Technologies, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on bioAffinity Technologies, Inc.
bioAffinity Technologies Appoints New Members to Board of Directors
SAN ANTONIO, Texas, August 18, 2025--bioAffinity Technologies appoints leaders in corporate finance and the diagnosis and ...
bioAffinity Technologies Secures $1.2M Through Private Placement
Affinity Technologies, Inc. ( (BIAF) ) just unveiled an announcement. On August 13, 2025, bioAffinity Technologies, Inc. entered into a securities purchase agreement with institutional and accredited ...
bioAffinity Technologies Sees Surge in CyPath® Lung Test Sales
Affinity Technologies, Inc. ( ($BIAF) ) has issued an update. On August 13, 2025, bioAffinity Technologies announced a significant increase in ...
bioAffinity Technologies Announces Closing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds
Affinity Technologies, Inc.(NASDAQ: BIAF, BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced the closing of its ...
BIAF - bioAffinity Technologies Inc News | Morningstar
News bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas’ Leadership Board Business Wire Jun 11, 2025, 1:00:00 PM ...
BIAF | bioAffinity Technologies Inc. Annual Income Statement | MarketWatch
bioAffinity Technologies Inc. Annual stock financials by MarketWatch. View the latest BIAF financial statements, income statements and financial ratios.
bioAffinity Technologies, Inc. Announces Closing of $7.8 Million ...
bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment.
bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024
bioAffinity Technologies Julie Anne Overton Director of Communications jao@bioaffinitytech.com Investor Relations Dave GentryRedChip Companies Inc. 1-800-RED-CHIP (733-2447) or 407-491-4498 BIAF ...
BIAFW bioAffinity Technologies, Inc. C/WTS 12/08/27 (TO PUR COM)
bioAffinity Technologies, Inc. C/WTS 12/08/27 (TO PUR COM) SEC Filing - Securities Registration Statement (S-1) November 27, 2024 SEC FilingsWed, Nov. 27, 2024 ...
bioAffinity Technologies, Inc. Announces Closing of $7.8 Million ...
bioAffinity Technologies, Inc. Announces Closing of $7.8 Million Initial Public Offering September 06, 2022 11:28 AM Eastern Daylight Time ...
Similar Companies
Loading the latest forecasts...